Concerto Biosciences

Concerto Biosciences

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://concertobio.com

Last Round

Series A

Nov 2, 2022

Total Funding Raised

$23.3M

Company Overview

Concerto Biosciences is a biotechnology company that develops microbe-based products by measuring and mapping microbial interactions to address needs in skin health, women's health, and food science.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Application

Keywords

microbiome therapeuticsmicrobial discoverylive biotherapeuticshigh-throughput screeningdrug discovery platformAI for drug discoverymicrobial ensemblesmicrobiomemicrobial community screeningbiotech partnershipsclinical-stage biotechdermatologyatopic dermatitiswomen's healthmicrobial interaction datasetprebioticspostbiotics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Concerto Biosciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Concerto Biosciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ANov 2, 2022
GrantJul 1, 2022

Key People

Founding team and executive leadership

Jared Kehe

Cofounder And Chief Scientific Officer

Founding Team

Cheri Ackerman

Cofounder CEO

Founding Team

Bernardo Cervantes

Chief Operating Officer

Executive Team

Concerto Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 30, 2026

    Partnered with Sacco System for development and commercialisation.

  • Jan 29, 2025

    Stewart Campbell appointed as Independent Director.

Concerto Biosciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Concerto Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Concerto Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range33
Year Founded2020
Last FundingNov 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.